跳至主要内容
临床试验/NCT05123287
NCT05123287Unknown不适用

A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up

Second Affiliated Hospital, School of Medicine, Zhejiang University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2021年10月8日最近更新:
适应症
相关药物

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
1
主要终点
The mean intima-media thickness of the common carotid artery

研究概览

简要总结

A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up

详细描述

This is a perspective, self-controlled cohort study. This study aims to evaluate the effectiveness of anti-PD-1 mAbs (PD-1 immune checkpoint blockades) on atherosclerotic carotid plaques in those anti-PD-1 mAbs treated patients. The method for quantification and evaluation of atherosclerotic plaques are based on the: ① The mean intima-media thickness of the common carotid artery (Mean CCA thickness); ② The maximum intima-media thickness of the internal carotid artery (maximum ICA thickness); ③ Carotid plaque burden: by calculation of the plaque area of atherosclerotic plaques on the long axis direction of artery on the ultrasound images. By comparing the above-mentioned parameters at the same location of carotid artery in each patient when initiate the first-dose of anti-PD-1 mAbs therapy and 3 months post anti-PD-1 mAbs therapy. It is designed to assess the effectiveness of anti-PD-1 mAbs on the progression of carotid plaques.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •The age of subjects are between 18-90 years old (including 18 and 90 years old);
  • •All kinds of tumor diseases of subjects are acceptable;
  • •All kinds of PD-1 immune checkpoint blockades or dosages are acceptable;
  • •The subjects knew about the experiment and signed the informed consent voluntarily;
  • •The subjects plan to receive PD-1 immune checkpoint blockades and potentially to be treated for over 3 months;
  • •The subjects complicated with atherosclerotic carotid plaques.

排除标准

  • •Subjects stop receiving or changing the PD-1 immune checkpoint blockades during follow-up;
  • •Subjects are reluctant to continue to be involved in this study;
  • •Known pregnant and lactating women;
  • •The parameters (e.g., CCA intima-media, ICA intima-media or carotid plaque burden) could not be calculated because of the quality of ultrasound image;
  • •Other situations that the researchers judged were not suitable for inclusion.

结局指标

主要结局

The mean intima-media thickness of the common carotid artery

时间窗: 3 months

It was measured over a segment of the common carotid artery that was 1 cm long, located approximately 0.5 cm below the carotid-artery bulb, and considered not to contain any plaque (i.e., not to have any perceivable protrusion of the artery wall into the lumen).

Carotid plaque burden

时间窗: 3 months

Carotid plaque area measured by ultrasound (cross-sectional area of longitudinal views of all plaques seen) to quantify the increase or decrease of atherosclerotic carotid plaques.

The maximum intima-media thickness of the internal carotid artery

时间窗: 3 months

It was defined as the greatest intima-media thickness in either the right or left internal carotid artery extending from the bulb to 1 cm above the carotid sinus, ascertained from a total of four views on each side.

次要结局

未报告次要终点

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验